[PLX] YoY Quarter Result on 31-Mar-2012 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- 33.76%
YoY- -16.86%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
Revenue 5,097 7,383 3,968 3,728 6,000 1,141 0 -
PBT -5,972 -7,345 -4,321 0 -5,052 -7,955 0 -
Tax 28 38 0 -161 0 0 148 -24.22%
NP -5,972 -7,345 -4,321 -5,904 -5,052 -7,955 -5,183 2.38%
Tax Rate - - - - - - - -
Total Cost 11,069 14,728 8,289 9,632 11,052 9,096 5,183 13.47%
Ratio Analysis
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
NP Margin -117.17 -99.49 -108.90 -158.37 -84.20 -697.20 0.00 -
Per Share
31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 CAGR
EPS -0.06 -0.08 -0.05 -0.07 -0.06 -0.10 -0.07 -2.53%
EPS Diluted -0.06 -0.08 -0.05 -0.07 -0.06 -0.10 -0.07 -2.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.